Searched for
EARLIER GLENMARK PHARMACEUTICALS
These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...- Glenmark Life Sciences Q2 Results: Firm posts profit rise on API boostHowever, a nearly 18% rise in expenses ate into the company's core profit margin, which contracted to 29% from 30.2% a year earlier.
- Add Glenmark Pharmaceuticals, target price Rs 649: ICICI SecuritiesGlenmark Pharmaceuticals Ltd., incorporated in the year 1977, is a Mid Cap company (having a market cap of Rs 15966.49 Crore) operating in ...
- Glenmark Q3 results: Net profit up 30% at Rs 248 crConsolidated revenue of the company stood at Rs 2,786.76 crore for the quarter under consideration. It was Rs 2,735.56 crore crore for the ...
- Study shows Favipiravir provides multiple benefits in COVID-19 treatment: GlenmarkThe Phase 3 study with Favipiravir, sold under the brand name FabiFlu, by the company was conducted in 150 patients, it added. Favipiravir ...
- Favipiravir and Remdesivir get approval for treatment“Under an accelerated approval process at the Central Drugs Standard Control Organisation (CDSCO), the Subject Expert Committee (SEC) has r...
- Neutral Glenmark Pharmaceuticals with a target of Rs 960: UBSExpect base US biz to improve as a result of recent launches in dermatology. UBS has forecast a 33% EPS CAGR over FY16-18E for Glenmark Pha...
- Glenmark Pharmaceuticals gets two ANDA approvals from USFDAGlenmark Pharmaceuticals has received final approval from the US health regulator USFDA for oral contraceptives and leukemia treatment inje...
- Glenmark gets tentative USFDA nod to sell RufinamideGlenmark Pharmaceuticals today said it has been granted tentative approval by the US health regulator to sell Rufinamide.
- Glenmark Generics Inc files law suit to enforce licence pactThe agreement is with Triax Pharmaceuticals, Astellas Pharma Europe BV and Astellas Pharma International BV.
- Glenmark settles patent case with Janssen for generic tabletsGlenmark Pharmaceuticals today said it has settled litigation with Janssen Pharmaceuticals Inc over patent actions regarding generic oral c...
- Glenmark gets tentative nod from USFDA for migraine tabletsGlenmark Pharmaceuticals said it has received tentative approval from the US health regulator for generic Zolmitriptan tablets used for tre...
- Glenmark Pharma Q3 net nearly halvesDrugmaker Glenmark Pharmaceuticals Ltd's quarterly profit nearly halved on heavy foreign exchange losses from overseas borrowings despite r...
- Glenmark gets DCGI nod for phase III trials of diarrhoea drugGlenmark Pharmaceuticals today said it has received approval from Drug Controller General of India (DCGI) to conduct phase III trials for C...
- Glenmark receives $25 mn from Sanofi as upfront paymentFollowing that clearance, the deal has now become effective and Glenmark has also received the first upfront payment of USD 25 million, it ...
- Glenmark settles patent suit for skin lotion with NycomedFluticasone propionate 0.05 per cent lotion by Glenmark is generic version of Nycomed's 'Cultivate' lotion.
- Glenmark scores over Sanofi, Abbott in US patent challengeGlenmark Pharmaceutical has scored in its patent tussle with Sanofi Aventis and Abbott after the New Jersey district court upheld the chall...
- Glenmark inks licence, supply pact with TaroGlenmark Pharmaceuticals on Thursday said it has signed a licence and supply agreement with Israeli firm Taro Pharmaceuticals to sell a bra...
- Glenmark takes patent cover with drug dealGlenmark Pharmaceuticals issued exclusive marketing rights for cholesterol control ezetimibe to another generic company Par Pharmaceutical ...
- Glenmark's Swiss arm gets $15 mn milestone payment from Forest LabsGlenmark Pharmaceuticals SA, the Swiss subsidiary of Glenmark Pharmaceuticals, has received a milestone payment of $15 million from Forest ...
Load More
